We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
6701
CALL
Arbutus Biopharma
ABUS
$871M
$23K ﹤0.01%
5,900
-5,300
-47% -$26.1K
ABUS icon
6702
PUT
Arbutus Biopharma
ABUS
$871M
$23K ﹤0.01%
6,000
+4,300
+253% +$21.2K
ARDC
6703
Are Dynamic Credit Allocation Fund
ARDC
$296M
$23K ﹤0.01%
1,631
+1,463
+871% +$21.7K
AVK
6704
Advent Convertible and Income Fund
AVK
$540M
$23K ﹤0.01%
1,831
+29
+2% +$392
CTO
6705
CTO Realty Growth
CTO
$740M
$23K ﹤0.01%
1,595
+1,577
+8,761% +$24.7K
EDEN icon
6706
iShares MSCI Denmark ETF
EDEN
$204M
$23K ﹤0.01%
400
-149
-27% -$8.77K
EWH icon
6707
CALL
iShares MSCI Hong Kong ETF
EWH
$1.24B
$23K ﹤0.01%
1,000
-500
-33% -$11.3K
FSFG
6708
DELISTED
First Savings Financial Group
FSFG
$23K ﹤0.01%
1,326
-180
-12% -$3.62K
GLTR icon
6709
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.44B
$23K ﹤0.01%
360
JHS
6710
John Hancock Income Securities Trust
JHS
$127M
$23K ﹤0.01%
1,787
KIM icon
6711
PUT
Kimco Realty
KIM
$17.7B
$23K ﹤0.01%
1,600
-224,900
-99% -$3.53M
SBIO icon
6712
ALPS Medical Breakthroughs ETF
SBIO
$202M
$23K ﹤0.01%
800
-700
-47% -$23.2K
SPFF icon
6713
Global X SuperIncome Preferred ETF
SPFF
$140M
$23K ﹤0.01%
2,103
TRAK icon
6714
ReposiTrak
TRAK
$159M
$23K ﹤0.01%
3,798
+114
+3% +$930
XPP icon
6715
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$9.34M
$23K ﹤0.01%
400
XT icon
6716
iShares Future Exponential Technologies ETF
XT
$3.77B
$23K ﹤0.01%
684
LUMO
6717
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$23K ﹤0.01%
1,645
-1,818
-52% -$32K
GBL
6718
DELISTED
GAMCO Investors, Inc.
GBL
$23K ﹤0.01%
1,388
+205
+17% +$4.19K
CLUB
6719
DELISTED
Town Sports International Holdings, Inc.
CLUB
$23K ﹤0.01%
3,740
-977
-21% -$7.39K
ABDC
6720
DELISTED
Alcentra Capital Corp
ABDC
$23K ﹤0.01%
3,500
TPGH.WS
6721
CALL
DELISTED
TPG Pace Holdings Corp. Warrants, each exercisable for one Class A Ordinary Share at an exercise pri
TPGH.WS
$23K ﹤0.01%
+22,398
New +$30.4K
MXWL
6722
DELISTED
Maxwell Technologies Inc
MXWL
$23K ﹤0.01%
10,999
-292
-3% -$790
MACK
6723
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$23K ﹤0.01%
+7,499
New +$26K
ESTE
6724
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$23K ﹤0.01%
5,070
-126
-2% -$951
GFN
6725
DELISTED
General Finance Corporation
GFN
$23K ﹤0.01%
2,191
-486
-18% -$6.33K

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.